The Centers for Disease Control and Prevention (CDC) has reported that more than 20 U.S. travelers returning from Cuba have tested positive for Oropouche virus, also known as sloth fever. This little-known disease is causing international concern as it spreads in South America and to countries where it has not been seen before.
Oropouche virus is primarily transmitted through the bites of infected midges, although some mosquitoes can also carry the virus. It was first discovered in Trinidad and Tobago in 1955 and has since been circulating in Latin America and the Caribbean, with sporadic outbreaks recorded in countries like Brazil and Peru. Symptoms of Oropouche virus infection can include fever, severe headache, joint and muscle pain, nausea, dizziness, chills, and sensitivity to light. Most people recover within a few days to a month, with symptoms lasting less than a week, but they can recur days or weeks later.
While most cases of Oropouche virus infection are mild, a small proportion of people (less than 5%) may develop more serious complications such as meningitis, brain inflammation, and bleeding. However, death from the virus is rare. Currently, there are no specific medicines to treat Oropouche or vaccines to prevent infection. The best way to protect against the disease is to prevent bites from midges and mosquitoes in areas where the virus is known to occur by using insect repellent and installing door and window screens.
The recent outbreak of Oropouche virus in South America has raised concerns due to the number of cases reported and the geographic spread of the virus. The outbreak has affected more than 8,000 people this year, reaching as far north as Cuba and as far south as Sao Paulo state in Brazil. While the virus is endemic in some parts of South America, the current outbreak is occurring in new areas outside the Amazon basin where the virus is usually found. Several countries, including the United States, Spain, Italy, and Germany, have reported cases linked to travel, but there is no evidence of sustained local transmission in these areas.
One of the reasons for concern is the first reports of deaths from the virus among otherwise healthy individuals in Brazil. There are also worries about the virus’s potential to spread from mother to fetus during pregnancy and its association with stillbirths, miscarriages, or birth defects. Scientists are still trying to understand what sparked the current outbreak and how the virus is evolving to adapt to new environments.
Although Oropouche virus is not a new threat, there is still much that remains unknown about the virus. Its ability to mutate rapidly and reassort its genome segments poses challenges for understanding and controlling the disease. The CDC has warned that Oropouche symptoms can be similar to those of other mosquito-borne diseases like dengue, chikungunya, Zika, or malaria, leading to misdiagnosis or confusion.
Despite the concerns surrounding the Oropouche virus outbreak, experts believe that it is unlikely to cause a global pandemic like COVID-19. Most people recover completely from Oropouche virus infection within a few weeks, and the virus is not as easily transmissible as other pathogens. Since its discovery, there have been approximately 500,000 cases of Oropouche fever recorded, according to The Lancet.
In conclusion, the Oropouche virus outbreak is a reminder of the ongoing threat posed by emerging infectious diseases and the importance of surveillance, prevention, and preparedness measures. As scientists continue to study the virus and develop strategies to combat it, it is essential for individuals to take precautions to avoid mosquito bites and stay informed about the latest developments in disease control and prevention.
